70 related articles for article (PubMed ID: 30213303)
21. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
22. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
23. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
24. [New perspectives for the diagnosis and prognosis of Graves' disease].
Tatulashvili S; Baudry C; Sadoul JL; Bihan H
Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S31-S39. PubMed ID: 30213303
[TBL] [Abstract][Full Text] [Related]
25. Role of genetic and non-genetic factors in the etiology of Graves' disease.
Marinò M; Latrofa F; Menconi F; Chiovato L; Vitti P
J Endocrinol Invest; 2015 Mar; 38(3):283-94. PubMed ID: 25421156
[TBL] [Abstract][Full Text] [Related]
26. Genetics of Graves' disease: the lost concept.
Sibarani RP
Acta Med Indones; 2009 Jan; 41(1):37-40. PubMed ID: 19258680
[TBL] [Abstract][Full Text] [Related]
27. Animal models of Graves' disease and Graves' orbitopathy.
Nagayama Y; Nakahara M; Abiru N
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):381-6. PubMed ID: 26181432
[TBL] [Abstract][Full Text] [Related]
28. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.
Jacobson EM; Tomer Y
J Autoimmun; 2007; 28(2-3):85-98. PubMed ID: 17369021
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype correlations in Graves' disease.
Radziszewski M; Kuś A; Bednarczuk T
Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101745. PubMed ID: 36828713
[TBL] [Abstract][Full Text] [Related]
30. Graves' disease: Introduction, epidemiology, endogenous and environmental pathogenic factors.
Wémeau JL; Klein M; Sadoul JL; Briet C; Vélayoudom-Céphise FL
Ann Endocrinol (Paris); 2018 Dec; 79(6):599-607. PubMed ID: 30342794
[TBL] [Abstract][Full Text] [Related]
31. Genetic predictors of the development and recurrence of Graves' disease.
Vejrazkova D; Vcelak J; Vaclavikova E; Vankova M; Zajickova K; Duskova M; Vrbikova J; Bendlova B
Physiol Res; 2018 Nov; 67(Suppl 3):S431-S439. PubMed ID: 30484670
[TBL] [Abstract][Full Text] [Related]
32. [Genetics of thyroid autoimmunity - update and clinical relevance].
Dultz G; Dittmar M; Kahaly GJ
Med Klin (Munich); 2009 Mar; 104(3):210-9. PubMed ID: 19337711
[TBL] [Abstract][Full Text] [Related]
33. The role of genetics in Graves' disease and thyroid orbitopathy.
Kim N; Hatton MP
Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
[TBL] [Abstract][Full Text] [Related]
34. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
35. Current insights into animal models of Graves' disease and orbitopathy.
Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
